171 related articles for article (PubMed ID: 28127742)
1. Performance comparison of NextSeq and Ion Proton platforms for molecular diagnosis of clinical oncology.
Cao F; Gao L; Wei L; Chen Z; Wang Y; Ran X; Meng X; Tao J
Tumori; 2017 May; 103(3):223-230. PubMed ID: 28127742
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
[No Abstract] [Full Text] [Related]
3. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours.
Singh RR; Patel KP; Routbort MJ; Aldape K; Lu X; Manekia J; Abraham R; Reddy NG; Barkoh BA; Veliyathu J; Medeiros LJ; Luthra R
Br J Cancer; 2014 Nov; 111(10):2014-23. PubMed ID: 25314059
[TBL] [Abstract][Full Text] [Related]
4. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
5. Comparison and evaluation of two exome capture kits and sequencing platforms for variant calling.
Zhang G; Wang J; Yang J; Li W; Deng Y; Li J; Huang J; Hu S; Zhang B
BMC Genomics; 2015 Aug; 16(1):581. PubMed ID: 26242175
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics.
Misyura M; Zhang T; Sukhai MA; Thomas M; Garg S; Kamel-Reid S; Stockley TL
J Mol Diagn; 2016 Nov; 18(6):842-850. PubMed ID: 27770852
[TBL] [Abstract][Full Text] [Related]
7. Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory.
Mehrotra M; Duose DY; Singh RR; Barkoh BA; Manekia J; Harmon MA; Patel KP; Routbort MJ; Medeiros LJ; Wistuba II; Luthra R
PLoS One; 2017; 12(8):e0181968. PubMed ID: 28767674
[TBL] [Abstract][Full Text] [Related]
8. Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data.
Wang Q; Kotoula V; Hsu PC; Papadopoulou K; Ho JWK; Fountzilas G; Giannoulatou E
BMC Med Genomics; 2019 Dec; 12(Suppl 9):181. PubMed ID: 31874647
[TBL] [Abstract][Full Text] [Related]
9. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
[TBL] [Abstract][Full Text] [Related]
10. Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens.
Hadd AG; Houghton J; Choudhary A; Sah S; Chen L; Marko AC; Sanford T; Buddavarapu K; Krosting J; Garmire L; Wylie D; Shinde R; Beaudenon S; Alexander EK; Mambo E; Adai AT; Latham GJ
J Mol Diagn; 2013 Mar; 15(2):234-47. PubMed ID: 23321017
[TBL] [Abstract][Full Text] [Related]
11. Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.
Vanni I; Coco S; Truini A; Rusmini M; Dal Bello MG; Alama A; Banelli B; Mora M; Rijavec E; Barletta G; Genova C; Biello F; Maggioni C; Grossi F
Int J Mol Sci; 2015 Dec; 16(12):28765-82. PubMed ID: 26633390
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use.
Shi Z; Lopez J; Kalliney W; Sutton B; Simpson J; Maggert K; Liu S; Wan J; Stack MS
PLoS One; 2022; 17(4):e0266914. PubMed ID: 35446881
[TBL] [Abstract][Full Text] [Related]
13. Performance comparison of whole-genome sequencing platforms.
Lam HY; Clark MJ; Chen R; Chen R; Natsoulis G; O'Huallachain M; Dewey FE; Habegger L; Ashley EA; Gerstein MB; Butte AJ; Ji HP; Snyder M
Nat Biotechnol; 2011 Dec; 30(1):78-82. PubMed ID: 22178993
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an ultra-high sensitive next-generation sequencing assay for molecular diagnosis of clinical oncology.
Liang J; She Y; Zhu J; Wei L; Zhang L; Gao L; Wang Y; Xing J; Guo Y; Meng X; Li P
Int J Oncol; 2016 Nov; 49(5):2088-2104. PubMed ID: 27826616
[TBL] [Abstract][Full Text] [Related]
15. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
Gailey MP; Stence AA; Jensen CS; Ma D
Cancer Cytopathol; 2015 Jan; 123(1):30-9. PubMed ID: 25186473
[TBL] [Abstract][Full Text] [Related]
16. Validation of a Customized Bioinformatics Pipeline for a Clinical Next-Generation Sequencing Test Targeting Solid Tumor-Associated Variants.
Schneider T; Smith GH; Rossi MR; Hill CE; Zhang L
J Mol Diagn; 2018 May; 20(3):355-365. PubMed ID: 29471113
[TBL] [Abstract][Full Text] [Related]
17. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
[TBL] [Abstract][Full Text] [Related]
18. A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma.
Shao D; Lin Y; Liu J; Wan L; Liu Z; Cheng S; Fei L; Deng R; Wang J; Chen X; Liu L; Gu X; Liang W; He P; Wang J; Ye M; He J
Sci Rep; 2016 Mar; 6():22338. PubMed ID: 26936516
[TBL] [Abstract][Full Text] [Related]
19. GLM-based optimization of NGS data analysis: A case study of Roche 454, Ion Torrent PGM and Illumina NextSeq sequencing data.
Sandmann S; de Graaf AO; van der Reijden BA; Jansen JH; Dugas M
PLoS One; 2017; 12(2):e0171983. PubMed ID: 28222155
[TBL] [Abstract][Full Text] [Related]
20. Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer.
Wang SR; Malik S; Tan IB; Chan YS; Hoi Q; Ow JL; He CZ; Ching CE; Poh DYS; Seah HM; Cheung KHT; Perumal D; Devasia AG; Pan L; Ang S; Lee SE; Ten R; Chua C; Tan DSW; Qu JZZ; Bylstra YM; Lim L; Lezhava A; Ng PC; Wong CW; Lim T; Tan P
J Mol Diagn; 2016 May; 18(3):416-424. PubMed ID: 26970585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
